pridopidine (ACR16)

pridopidine · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pridopidine (ACR16), covering 2023-08-29 to 2023-08-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease [Phase 3]